NEU neuren pharmaceuticals limited

Possible outcomes?, page-6

  1. 562 Posts.
    lightbulb Created with Sketch.  16
    I wonder if there is another option - the outright sale (licensing?) of Trofinetide.

    I don't see that as viable, for reasons I've stated before i.e. because that would leave a cashed up NEU with 2591 to develop (or as I think of it: Trofinetide 2.0). But this is another option that I don't see listed in your message above Baldwix, and it is a possibility.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
$17.01
Change
-0.640(3.63%)
Mkt cap ! $2.229B
Open High Low Volume
$17.49 $17.72 $16.84 751.6K

Buyers (Bids)

Vol. Price($)
438 $16.99
 

Sellers (Offers)

Price($) Vol.
$17.02 518
Last trade - 16.26pm 02/07/2026 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.